INTERNATIONAL PHYTOMEDICINES INSTITUTE (IPI)
From Farm to Bedside: Health and Wealth from Medicinal Plants
The International Phytomedicine and Medical Cannabis Institute (IPI) is a high impact collaborative initiative launched during the Global Health Catalyst summit at Harvard Medical School in 2019. This was powered by a touch-down donation from NFL Hall of Famer Calvin Johnson, major collaborations with industry and government leaders including the Minister of Industry, Commerce, Agriculture and Fisheries of Jamaica the Honorable Audley Shaw
COLLABORATING ON PHYTOMEDICINES INCLUDING MEDICAL CANNABIS
The IPI is focused on high impact collaborations on evidence-based phytomedicines for global health and economic development working with partners from industry, academic institutions, policy makers, and millions of stakeholders around the world
Consultation on evidence-based phytomedicines and OUTREACH: Opportunities with, industry partners and stakeholders across the world including during the global health catalyst summits
Leading -edge research for superior product quality assurance and evidence-based phytomedicines
Providing world-class education and training on evidence-based phytomedicines from farm to Bedside.
Interview with NFL Hall of Famer Calvin Johnson during the Global Health Catalyst Summit at Johns Hopkins
All the Latest
LAUNCH OF EDUCATION PROGRAM ON MEDICAL CANNABIS
July 10, 2022
One of the outcomes of the 2023 Global Health Catalyst summit at Johns Hopkins was the launch of a new education series and courses on medical cannabis. The initiative was launched with NFL Hall of Famer Calvin Johnson and collaborators from leading institutions in the USA, Europe, Africa and South America. Courses will start April 1, 2023 along with educational content that will be distributed widely to educate the public on Medical Cannabis
NEW PUBLICATION FROM FACULTY AT THE UNIVERSITY OF PENNSYLVANIA, JOHNS HOPKINS AND HARVARD ON PHYTORADIOTHERAPY
January 26, 2023
In the published study, a protocol for testing the radiosensitizing effects of phytomedicines was validated and used to investigate the well-known plant based medicine cannabidiol (CBD) and the lesser-known medicinal fruit Bitter Melon. Additionally, based on its high concentration of plant hemoglobin which has been shown to abate hypoxia, the African-indigenous Justicia plant was tested in pancreatic adenocarcinoma mouse models.
MEETING WITH JAMAICA MINISTER ON COLLABORATIONS FROM FARM TO BEDSIDE: HEALTH AND ECONOMIC DEVELOPMENT
October 1, 20
Industry, Commerce, Agriculture and Fisheries Minister, Audley Shaw, met on plans to establish an international centre on phytomedicine and Medical Cannabis in Jamaica to further advance plant-based medicine research. This will involve collaborations with noted Jamaican scientist and businessman, Dr. Henry Lowe; Dr. Julius Garvey, son of National Hero, the Right Excellent Marcus Garvey; and collaborator from Harvard University Medical School in the United States, Dr. Wilfred Ngwa
STUDY ON CANNABIS CHEMICAL AT HARVARD SHOWS POTENTIAL IN TREATMENT OF PANCREATIC CANCER
August 20, 2019
Scientists from Harvard University’s Dana-Farber Cancer Institute have released some much-needed good news. In their study, published in the journal Frontiers of Oncology on July 23, the researchers revealed that a chemical found in cannabis has demonstrated “significant therapy potential” in treatment of pancreatic cancer.
AMERICA HAS A PAIN PROBLEM, INCLUDING CANCER PATIENTS. CAN CANNABIS HELP?
December 11, 2022
Patients with cancer suffer enormous pain. On any given day, almost half of working-age men who are not in the labor force take pain medication, and people with chronic pain miss nine more days of work a year than those without it. Experts weigh in on cannabis as a phytomedicine for pain relief
HIGH IMPACT COLLABORATIONS
FROM FARM TO BEDSIDE: THE WORLD’S PREMIER INTERNATIONAL PHYTOMEDICINES INSTITUTE
June 9, 2019
Dedicated to Research and Education focused on developing Evidence-based phytomedicines for global health and economic development. Leveraging the best science, technology and education from world leading institutions and industry partner institutions to convert potential high impact medicinal plants to evidence-based pharmaceutical grade products for global health and economic development